Vivek Dhawan

1.5k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Vivek Dhawan is a scholar working on Molecular Biology, Biomaterials and Infectious Diseases. According to data from OpenAlex, Vivek Dhawan has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Biomaterials and 3 papers in Infectious Diseases. Recurrent topics in Vivek Dhawan's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Vivek Dhawan is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Vivek Dhawan collaborates with scholars based in India, Canada and Germany. Vivek Dhawan's co-authors include Mangal S. Nagarsenker, Sanket Shah, René Holm, Yvonne Perrie, Alex Bunker, Aniket Magarkar, Tomasz Róg, Tapani Viitala, Mohammed Elmowafy and Paraskevi Kallinteri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Vivek Dhawan

24 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liposomes: Advancements and innovation in the manufacturing process

2020 524 citations Sanket Shah, Vivek Dhawan et al. Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by Vivek Dhawan

Since Specialization

Citations

This map shows the geographic impact of Vivek Dhawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Dhawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Dhawan more than expected).

Fields of papers citing papers by Vivek Dhawan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Dhawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Dhawan. The network helps show where Vivek Dhawan may publish in the future.

Co-authorship network of co-authors of Vivek Dhawan

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Dhawan. A scholar is included among the top collaborators of Vivek Dhawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Dhawan. Vivek Dhawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Empyema necessitans: a rare presentation of Mycobacterium tuberculosis infection 2024 ·Canadian Medical Association Journal ·(unknown), (unknown), Vivek Dhawan	1
2	Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate – A nano-strategic approach and comparative assessment of hepatospecificity 2022 ·International Journal of Pharmaceutics ·Vivek Dhawan, Abhijeet Lokras, (unknown), (unknown), (unknown), Bhabani Mohanty, (unknown), Pradip Chaudhari, (unknown), M. N. Saraf, (unknown)	7
3	Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting – Synthesis and comparative in silico and in vitro assessment 2021 ·Carbohydrate Research ·Vivek Dhawan, (unknown), Brijesh Sutariya, (unknown), Mukul Ashtikar, (unknown), Frank Steiniger, Abhijeet Lokras, Alfred Fahr, (unknown), (unknown), M. N. Saraf, (unknown)	3
4	Liposomes: Advancements and innovation in the manufacturing process breakdown → 2020 ·Advanced Drug Delivery Reviews ·Sanket Shah, Vivek Dhawan, René Holm, Mangal S. Nagarsenker, Yvonne Perrie	524
5	Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation 2020 ·International Journal of Pharmaceutics ·Vivek Dhawan, Brijesh Sutariya, Abhijeet Lokras, Jana Thamm, M. N. Saraf, (unknown), Alfred Fahr, (unknown)	4
6	Lipid Architectonics for Superior Oral Bioavailability of Nelfinavir Mesylate: Comparative in vitro and in vivo Assessment 2018 ·AAPS PharmSciTech ·(unknown), (unknown), Vivek Dhawan, Vinay Sridhar, Anuradha Majumdar, Rute Nunes, Francisca Araújo, Bruno Sarmento, (unknown), Frank Steiniger, Alfred Fahr, Aniket Magarkar, Alex Bunker, Mangal S. Nagarsenker	12
7	Towards the elimination of paediatric tuberculosis in high-income, immigrant-receiving countries: a 25-year conventional and molecular epidemiological case study 2018 ·ERJ Open Research ·Vivek Dhawan, (unknown), Angela Lau, Deanne Langlois-Klassen, Dennis Kunimoto, Ravi Bhargava, Linda Chui, Simon M. Collin, Richard Long	6
8	Catanionic systems in nanotherapeutics – Biophysical aspects and novel trends in drug delivery applications 2017 ·Journal of Controlled Release ·Vivek Dhawan, Mangal S. Nagarsenker	46
9	Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silic o modeling, in vitro and in vivo evaluation 2016 ·International Journal of Pharmaceutics ·(unknown), Vivek Dhawan, Aniket Magarkar, Reinis Danne, Srinath Govindarajan, (unknown), Frank Steiniger, Pradip Chaudhari, Vijaya Gopal, Alex Bunker, Tomasz Róg, Alfred Fahr, Mangal S. Nagarsenker	31
10	In Vitro and Ex Vivo Evaluations of Lipid Anti-Cancer Nanoformulations: Insights and Assessment of Bioavailability Enhancement 2016 ·AAPS PharmSciTech ·Ankitkumar S. Jain, Vivek Dhawan, Bruno Sarmento, Mangal S. Nagarsenker	20
11	Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery 2015 ·Carbohydrate Research ·(unknown), Mangal S. Nagarsenker, (unknown), (unknown), Vivek Dhawan, Dibyendu Bhattacharyya, C. L. Viswanathan, Frank Steiniger, Alfred Fahr	29
12	Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: In vitro and in vivo evaluation 2014 ·Biomedicine & Pharmacotherapy ·Ankitkumar S. Jain, Peeyush N. Goel, Sanket Shah, Vivek Dhawan, (unknown), Rajiv P. Gude, Mangal S. Nagarsenker	38
13	Apoptosis induction and anti-cancer activity of LeciPlex formulations 2014 ·Cellular Oncology ·Vivek Dhawan, (unknown), Ankitkumar S. Jain, (unknown), Rajiv P. Gude, Rita Mulherkar, Mangal S. Nagarsenker	16
14	Cationic nanoemulsions as potential carriers for intracellular delivery 2014 ·Saudi Pharmaceutical Journal ·(unknown), (unknown), Vivek Dhawan, (unknown), Abhijit A. Date, Rita Mulherkar, Mangal S. Nagarsenker	38
15	Cholesterol level affects surface charge of lipid membranes in saline solution 2014 ·Scientific Reports ·Aniket Magarkar, Vivek Dhawan, Paraskevi Kallinteri, Tapani Viitala, Mohammed Elmowafy, Tomasz Róg, Alex Bunker	174
16	Lecithin-Based Novel Cationic Nanocarriers (Leciplex) II: Improving Therapeutic Efficacy of Quercetin on Oral Administration 2011 ·Molecular Pharmaceutics ·Abhijit A. Date, Mangal S. Nagarsenker, (unknown), Vivek Dhawan, (unknown), P. A. Hassan, Vinod K. Aswal, Frank Steiniger, Jana Thamm, Alfred Fahr	97
17	Gastric Intramural Hematoma: A Case Report and Literature Review 2009 ·SHILAP Revista de lepidopterología ·Vivek Dhawan, (unknown), Richard N. Fedorak	36
18	Bimodal effects of chronically administered neurokinin B (NKB) on in vivo and in vitro cardiovascular responses in female rats 2007 ·Regulatory Peptides ·Jing Yang, Vivek Dhawan, Donald W. Morrish, Susan Kaufman	4
19	Repeated pregnancies (multiparity) increases venous tone and reduces compliance 2005 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Vivek Dhawan, Zoë Brookes, Susan Kaufman	9
20	Long-term effects of repeated pregnancies (multiparity) on blood pressure regulation 2004 ·Cardiovascular Research ·Vivek Dhawan, Zoë Brookes, Stuart S. Kaufman	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact